EXANE DERIVATIVES - ABERDEEN STD GOLD ETF TR ownership

ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 226 filers reported holding ABERDEEN STD GOLD ETF TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of ABERDEEN STD GOLD ETF TR
ValueSharesWeighting
Q1 2022$4,310,220,000
+12.3%
231,996
+6.1%
1.21%
+30.7%
Q4 2021$3,838,530,000
+4.2%
218,6030.0%0.93%
+5.1%
Q3 2021$3,683,328,000
-32.0%
218,603
-29.9%
0.88%
-28.0%
Q2 2021$5,413,706,000
+5.9%
311,6770.0%1.23%
-15.9%
Q1 2021$5,111,277,000311,6771.46%
Other shareholders
ABERDEEN STD GOLD ETF TR shareholders Q2 2022
NameSharesValueWeighting ↓
Mountain Lake Investment Management LLC 715,000$12,491,0509.49%
STAPP WEALTH MANAGEMENT, PLLC 151,197$2,6426.33%
Ameliora Wealth Management Ltd. 483,191$8,441,3474.52%
Empirical Asset Management, LLC 228,797$3,997,0844.21%
MILESTONE ASSET MANAGEMENT, LLC 322,836$5,969,2383.55%
Cypress Capital, LLC 599,156$10,467,2553.46%
BOS Asset Management, LLC 208,270$3,638,4773.25%
WT Wealth Management 366,761$6,407,3163.11%
Newman Dignan & Sheerar, Inc. 537,044$9,382,1593.11%
Ethos Financial Group, LLC 510,399$8,914,5923.02%
View complete list of ABERDEEN STD GOLD ETF TR shareholders